It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Laparoscopic-Assisted Versus Open Resection for Rectal Cancer

Clinical Trial Title: 
Comparing laparoscopic-assisted resection versus open resection for rectal cancer
Clinical Trial Protocol ID: 
10071201
Clinical Trial Investigator Name: 
Marc Brand, MD
Clinical Trial Protocol Description: 

This study is comparing two types of surgery currently used for rectal cancer: laparoscopic-assisted rectal resection and open laparotomy rectal resection. Although laparoscopic-assisted rectal resection is being used for rectal cancer in some medical centers, there are still questions about whether this type of surgery is as effective as open surgery. About 480 study subjects will take part in this study. Approximately 25 subjects will be registered at Rush University Medical Center.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are greater than 18 years of age 
  • Have had a histologic diagnosis of adenocarcinoma of the rectum
  • Comple the pre-operative 5FU-based chemotherapy and/or radiation therapy. Capecitabine may be substituted for 5FU
  • Have T3 N0 M0, T1-3 N1-2 M0 disease as determined by pre-neoadjuvant therapy CT scans and pelvic MRI or transrectal ultrasound

You will be excluded from this study if you:

  • Have a BMI greater than 34

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Gastrointestinal Cancers
Contact Phone: 
(312) 942-7462
Contact Name: 
Amanda Francescatti